Oligodeoxynucleotides inhibit Toll-like receptor 3 mediated cytotoxicity and CXCL8 release in keratinocytes

Experimental Dermatology

Volumn 21, Issue 1, 2012, Pages 7-12

  Grimstad, Øystein ^a,b   Pukstad, Brita ^a,b   Stenvik, Jørgen ^a   Espevik, Terje ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Oligodeoxynucleotides; PolyI:C; Toll like receptor 3

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 8; OLIGODEOXYNUCLEOTIDE; POLYINOSINIC POLYCYTIDYLIC ACID; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 3;

ARTICLE; CYTOKINE RELEASE; CYTOTOXICITY; HUMAN; HUMAN CELL; INFLAMMATION; KERATINOCYTE; METABOLIC INHIBITION; UPREGULATION;

CELL LINE; CYCLOPROPANES; ENDOCYTOSIS; GUANOSINE; HUMANS; INTERLEUKIN-8; KERATINOCYTES; OLIGODEOXYRIBONUCLEOTIDES; POLY I-C; TOLL-LIKE RECEPTOR 3;

EID: 83555164631     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2011.01390.x     Document Type: Article

References (35)

1. Medzhitov R, Preston-Hurlburt P, Janeway C A Jr. Nature 1997: 388: 394-397.
2. Lotze M T, Zeh H J, Rubartelli A et al. Immunol Rev 2007: 220: 60-81.
3. Grimstad O, Sandanger O, Ryan L et al. Wound Repair Regen 2011: 19: 337-347.
4. Lai Y, Di Nardo A, Nakatsuji T et al. Nat Med 2009: 15: 1377-1382.
5. Palazzo M, Gariboldi S, Zanobbio L et al. Int Immunol 2008: 20: 709-718.
6. Weiner G J. J Leukoc Biol 2000: 68: 455-463.
7. Mempel M, Voelcker V, Kollisch G et al. J Invest Dermatol 2003: 121: 1389-1396.
8. Haas T, Metzger J, Schmitz F et al. Immunity 2008: 28: 315-323.
9. Vollmer J, Weeratna R D, Jurk M et al. Immunology 2004: 113: 212-223.
10. Dorn A, Ludwig R J, Bock A et al. J Invest Dermatol 2007: 127: 846-854.
11. Weber A, Kirejczyk Z, Besch R et al. Cell Death Differ 2010: 17: 942-951.
12. Alexopoulou L, Holt A C, Medzhitov R et al. Nature 2001: 413: 732-738.
13. Lemaire P A, Lary J, Cole J L. J Mol Biol 2005: 345: 81-90.
14. Clemens M J, Elia A. J Interferon Cytokine Res 1997: 17: 503-524.
15. Yoneyama M, Kikuchi M, Matsumoto K et al. J Immunol 2005: 175: 2851-2858.
16. Kato H, Takeuchi O, Mikamo-Satoh E et al. J Exp Med 2008: 205: 1601-1610.
17. Gill N, Deacon P M, Lichty B et al. J Virol 2006: 80: 9943-9950.
18. Rose W A II, McGowin C L, Pyles R B. Virol J 2009: 6: 195.
19. Dogusan Z, Garcã-a M N, Flamez D et al. Diabetes 2008: 57: 1236-1245.
20. Salaun B, Coste I, Rissoan M-C et al. J Immunol 2006: 176: 4894-4901.
21. Scaffidi P, Misteli T, Bianchi M E. Nature 2002: 418: 191-195.
22. Bell C W, Jiang W, Reich C F III et al. Am J Physiol Cell Physiol 2006: 291: C1318-C1325.
23. Savill J, Dransfield I, Gregory C et al. Nat Rev Immunol 2002: 2: 965-975.
24. Orrenius S, Nicotera P, Zhivotovsky B. Toxicol Sci 2011: 119: 3-19.
25. Itoh K, Watanabe A, Funami K et al. J Immunol 2008: 181: 5522-5529.
26. Yakubov L A, Deeva E A, Zarytova V F et al. Proc Natl Acad Sci U S A 1989: 86: 6454-6458.
27. Loke S L, Stein C A, Zhang X H et al. Proc Natl Acad Sci U S A 1989: 86: 3474-3478.
28. Zhu F G, Reich C F, Pisetsky D S. Immunology 2001: 103: 226-234.
29. Biessen E A, Vietsch H, Kuiper J et al. Mol Pharmacol 1998: 53: 262-269.
30. Sato T, Yamamoto M, Shimosato T et al. Accelerated wound healing mediated by activation of Toll-like receptor 9. Wound Repair Regen 2010: 18: 586-593.
31. Rachmilewitz D, Karmeli F, Shteingart S et al. Inflamm Bowel Dis 2006: 12: 339-345.
32. Klinman D, Shirota H, Tross D et al. J Leukoc Biol 2008: 84: 958-964.
33. Inoue J, Aramaki Y. J Immunol 2007: 178: 584-591.
34. Lee K H, Cho K A, Kim J Y et al. Exp Dermatol 2011: 20: 149-151.
35. Yoshizumi M, Nakamura T, Kato M et al. Cell Biol Int 2008: 32: 1405-1411.